Three of the CLL samples tested were derived from patients with known mutations in BIRC3, that are associated with NIK stabilization and consequent p100 processing resulting in the nuclear translocation of p52. This evidence concerns the gene BIRC3 and B-cell chronic lymphocytic leukemia.